The concordance of HER2 in this series are in keeping with other studies (31, 32) and suggest that there are intrinsic differences between DCIS lesions that can and should be identified at diagnosis and that may help us to improve management in the future. Here, ERBB2 is linked to ductal breast carcinoma in situ.